Connect with us

Hi, what are you looking for?

Smart Investment StepsSmart Investment Steps

Investing

Trump plans to meet with Venezuela opposition leader Maria Corina Machado next week

President Donald Trump said on Thursday that he plans to meet with Venezuelan opposition leader Maria Corina Machado in Washington next week.

During an appearance on Fox News’ ‘Hannity,’ Trump was asked if he intends to meet with Machado after the U.S. struck Venezuela and captured its president, Nicolás Maduro.

‘Well, I understand she’s coming in next week sometime, and I look forward to saying hello to her,’ Trump said.

This will be Trump’s first meeting with Machado, who the U.S. president stated ‘doesn’t have the support within or the respect within the country’ to lead.

According to reports, Trump’s refusal to support Machado was linked to her accepting the 2025 Nobel Peace Prize, which Trump believed he deserved.

But Trump later told NBC News that while he believed Machado should not have won the award, her acceptance of the prize had ‘nothing to do with my decision’ about the prospect of her leading Venezuela.

This post appeared first on FOX NEWS

Enter Your Information Below To Receive Latest News and Articles




    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Investing

    Nasry Asfura has won the 2025 Honduras presidential election, delivering victory for the right-of-center National Party of Honduras (PNH) and shifting the political landscape...

    Editor's Pick

    (TheNewswire)   December 24th, 2025 TheNewswire – Muskoka, Ontario Steadright Critical Minerals Inc. (CSE: SCM,OTC:SCMNF) (‘Steadright’ or the ‘Company’) Board of Directors has approved...

    Editor's Pick

    Silverco Mining Ltd. (TSXV: SICO) (‘Silverco’ or the ‘Company’) announces that at the request of CIRO, Silverco wishes to confirm that the Company’s management...

    Editor's Pick

    The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy tailwinds. This combination is...

    Disclaimer: smartinvestmentsteps.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 smartinvestmentsteps.com